News

Under the agreement, Abbott will develop a test to detect extra copies of the epidermal growth factor receptor gene using its proprietary fluorescence in situ hybridization technology in

Under terms of the agreement, Daiichi Sankyo will receive upfront payments, payments pursuant to the achievement of certain milestones, and royalties on product sales. Raymond Warrell, Jr., chairman

The MAA will be reviewed by the Committee for Medicinal Products for Human Use (CHMP), subject to validation by the European Medicines Agency. Aztreonam lysine is an investigational

This partnership follows an agreement signed in 2007 between Galderma and Zars Pharma for the promotion and distribution of Pliaglis in the US and Canada. Humberto Antunes, CEO

The panel has ruled that the patents covering the active ingredient and a pharmaceutical composition thereof are valid, enforceable and infringed by the generic manufacturer’s product. In the

Pharmion shareholders will receive $25 in cash and 0.84 Celgene shares for each share of Pharmion stock owned. The transaction brings together three medically meaningful therapies, Revlimid, Thalomid

After completing its review and delivering a report of its findings to Neuro-Hitech, Numoda will also assist the company in interpreting and presenting the results to potential licensing

The termination will become effective in 90 days. The termination of the agreement also results in the termination of the Air Insulin supply agreement. Alkermes is evaluating the

The acquisition consists of an initial cash payment of $24 million, guaranteed minimum future payments of $3.7 million and potential additional cash payments based upon the future operational